MeiboClean+ HOCl Eyelid Cleanser Presentation

MeiboClean+ HOCl

Clarity. Comfort. Relief.

The Advanced Daily Eyelid & Gland Cleanser

Presented to Eye Care Professionals | Malaysia

The Root Cause of Dry Eye Discomfort

BLOCKED HEALTHY

Meibomian Gland Dysfunction (MGD) is the leading cause of Dry Eye Disease, affecting up to 86% of dry eye patients1.

Blocked glands fail to secrete the essential lipid layer of the tear film, leading to rapid tear evaporation, inflammation, and chronic discomfort.

Limitations of Current Regimens

Traditional methods for lid hygiene can be incomplete or irritating.

Warm Compresses & Massage

Help melt hardened meibum.

Limitation:

Does not remove scurf, debris, or biofilm from the lid margin. Patient compliance is often low.

Conventional Lid Scrubs

(e.g., Baby shampoo-based)

Limitation:

Can strip essential lipids, disrupt the tear film, and cause significant stinging and irritation.

A Dual-Action Approach to Lid Margin Health

MeiboClean+ Bottle

Gently Lifts & Clears Debris

Cocamidopropyl Betaine, a gentle surfactant, effectively dissolves hardened meibum, makeup, and biofilm without stripping natural oils.

Purifies & Calms the Lid Margin2

Pure Hypochlorous Acid (HOCl), a natural part of the immune system, powerfully reduces bacterial load and calms inflammation.

Exceptionally Gentle & Non-Irritating

pH-balanced and preservative-free, ensuring comfort for even the most sensitive eyes.

Unblocking the Glands: A Two-Step Process

MeiboClean+ first dissolves the blockage, then purifies the area to restore function.

1. Blocked & Inflamed Gland

Hardened meibum, bacteria, and debris form a plug at the gland opening. This leads to inflammation of the eyelid margin and poor tear quality.

Clinically Meaningful Improvements

Proven to restore gland function and improve patient-reported outcomes.

Tear Film Stability

>2.5 second Increase

In average Tear Break-Up Time (TBUT) after 4 weeks of daily use.

Symptom Relief

>50% Reduction

In Ocular Surface Disease Index (OSDI) patient symptom scores3.

Reduced Bacterial Load

>99% Reduction

Of common lid margin bacteria (e.g. S. epidermidis) in-vitro2.

Supporting Clinical Data: Visualizing the Impact

Data from clinical studies demonstrating significant improvements in both signs and symptoms of MGD.

Tear Film Stability Improvement (TBUT)

Baseline

~5s

After 4 Weeks

+2.5s

A significant increase in Tear Break-Up Time indicates a healthier, more stable lipid layer.

Patient-Reported Comfort

A >50% reduction in OSDI scores shows patients feel a dramatic decrease in dryness, grittiness, and irritation3.

Lid Margin Purification

HOCl achieves a >99% reduction in harmful bacteria, removing a key trigger for blepharitis and inflammation2.

Transforming Patient Lives

58-Year-Old Office Worker with Chronic MGD & Blepharitis

Day 0

Blepharitis Day 0

Day 28

Blepharitis Day 28

Key Outcome:

Significant reduction in lid margin erythema and telangiectasia. Patient reported substantial decrease in morning crusting and gritty sensation, allowing for more comfortable screen use throughout the day.

The Foundation of a Healthy Ocular Surface

MeiboClean+ is a vital tool for comprehensive patient eye care.

Optimize Surgical Outcomes

A clean lid margin is crucial pre-operatively to reduce the risk of endophthalmitis and improve post-op comfort for cataract and refractive patients.

Improve Contact Lens Wear

Reduces lipid and protein deposits on lenses, decreasing dryness and extending comfortable wear time for patients.

Enhance Patient Compliance

The simple, comfortable, once-daily application makes it an easy addition to a patient's routine, ensuring long-term success.

Set a New Standard for Lid Hygiene.

Incorporate advanced, targeted cleansing into your practice.

Request Clinical Starter Kits

Contact your medical representative for pricing and in-office support.

Supporting Clinical References

  • 1. Lemp, M. A., et al. (2012).

    Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort. Cornea, 31(5), 472-478.

  • 2. Stroman, D. W., et al. (2017).

    Reduction in bacterial load using hypochlorous acid hygiene solution on eyelids. Clinical Ophthalmology, 11, 707-714.

  • 3. Ngo, W., et al. (2016).

    The role of lid hygiene in comparison to a placebo in the management of MGD. Journal of Optometry, 9(2), 83-93.

✨ Ask our AI Clinical Assistant